| 1 |
LU2314628996 |
JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR |
+32,75 % |
+20,44 % |
1,47 |
| 2 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
+36,24 % |
+23,45 % |
1,43 |
| 3 |
LU1725387622 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating |
+22,37 % |
+14,32 % |
1,37 |
| 4 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
+22,19 % |
+14,32 % |
1,36 |
| 5 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
+21,34 % |
+14,33 % |
1,30 |
|
|
| 116 |
CH0113817123 |
Bellevue Biotech DT CHF |
+15,56 % |
+20,51 % |
0,63 |
| 117 |
LU1176840327 |
Protea Fund - Sectoral Biotech Opportunities Fund PF USD |
+15,47 % |
+22,06 % |
0,58 |
| 118 |
LU3110815787 |
CPR Invest - Biodiversity - IF1 EURH1 - Acc |
+8,97 % |
+11,69 % |
0,53 |
| 119 |
LU3110815944 |
CPR Invest - Biodiversity - IF2 EURH1 - Acc |
+8,75 % |
+11,69 % |
0,52 |
| 120 |
LU1711916616 |
Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF |
+10,91 % |
+21,96 % |
0,37 |